nalidixic acid has been researched along with carbostyril in 152 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (15.13) | 18.7374 |
| 1990's | 24 (15.79) | 18.2507 |
| 2000's | 51 (33.55) | 29.6817 |
| 2010's | 46 (30.26) | 24.3611 |
| 2020's | 8 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Cárdenas, AM; Cortés, MP; Fernández, E; Peña, W | 1 |
| Gootz, TD; Martin, BA | 1 |
| Bailey, DL; Epling, GA; Kiely, JS; Robertson, DG; Song, B | 1 |
| Hall, MC; Piddock, LJ; Walters, RN | 1 |
| Lewin, CS | 1 |
| Bendele, AM; Chandrasekhar, S; Harvey, AK; Hrubey, PS; Hulman, JF | 1 |
| Bhattacharya, SS; Lal, HM; Lalitha, MK; Nisha, AK; Ramamoorthy, U | 1 |
| Chu, DW; Cooper, CS; Mitscher, LA; O'Donnell, TJ; Pernet, AG; Rosen, T; Sharma, PN; Shen, LL | 1 |
| Barry, AL; Jones, RN | 1 |
| Kato, H; Nagata, O; Nakamura, M; Okezaki, E; Terasaki, T; Tsuji, A | 1 |
| Carr, H; Czinn, SJ; Hupertz, V | 1 |
| Senf, HJ | 1 |
| Rehavi, M; Rubinstein, E; Segev, S | 1 |
| Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL | 2 |
| Cremer, AW; Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL; Robbins, MJ; Wall, RA; Williams, AH | 1 |
| Forth, W | 1 |
| Angehrn, P; Dix, BA; Georgopapadakou, NH; Olson, GL; Wick, A | 1 |
| Oliva, B; Ravagnan, G; Renzini, G; Selan, L | 1 |
| Baltch, AL; Conroy, JV; Hammer, MC; Smith, RP | 1 |
| Smith, JT | 1 |
| Neu, HC | 1 |
| Jensen, KM; Madsen, PO | 1 |
| Bebear, C; Cantet, P; Quentin, C; Renaudin, H | 1 |
| Gabriel, FG; Mumtaz, G; Oriel, JD; Ridgway, GL | 1 |
| Peeters, M; Piot, P; Van Dyck, E | 1 |
| Dørflinger, T; Frimodt-Møller, PC; Madsen, PO | 1 |
| Husson, MO; Izard, D; Leclerc, H | 1 |
| Fuzi, M | 1 |
| Gruninger, RP; Khan, MY; Siddiqui, Y | 1 |
| Gensberg, K; Jin, YF; Piddock, LJ | 1 |
| Kasatkina, IV; Lozovoĭ, NV; Pasiukov, VV; Shcherbaniuk, AI | 1 |
| Griggs, DJ; Hall, MC; Jin, YF; Piddock, LJ | 1 |
| Phillips, I; Power, EG | 1 |
| Hayashibara, M; Ichikawa, N; Iwamoto, K; Naora, K | 1 |
| Amyes, SG; Brown, JC; Jesudason, MV; Shanahan, PM; Thomson, CJ | 1 |
| Klecak, G; Urbach, F; Urwyler, H | 1 |
| Forbes, PD; Mäkinen, M; Stenbäck, F | 1 |
| Neumann, S; Quiñones, A | 1 |
| Belicová, A; Ebringer, L; Ilavský, D; Milata, V; Seman, M | 1 |
| Sanders, CC; Thomson, KS | 1 |
| Chignell, CF; Martínez, L | 1 |
| Avril, JL; Bonnier, M; Donnio, PY; Heurtin-Le Corre, C; Lacourt, A; Travert, MF | 1 |
| Asuquo, AE; Jin, YF; Piddock, LJ; Ricci, V | 1 |
| Borrego, JJ; Capitano, L; Castro, D; Hatha, M; Nuñez, L; Ruiz, J; Sierra, JM; Vila, J | 1 |
| Helmuth, R; Malorny, B; Schroeter, A | 1 |
| Akagi, M; Fukuishi, N; Kanoh, R; Matsui, N | 1 |
| Hiraku, Y; Kawanishi, S | 2 |
| Chaslus-Dancla, E; Cloeckaert, A; Dho-Moulin, M; Flaujac, G; Giraud, E; Leroy-Sétrin, S | 1 |
| Bleczinski, CF; Connors, WH; Kryatova, OP; Mokhir, AA; Richert, C | 1 |
| Barry, J; Egan, J; Hill, M; McFaddyen, S; McNamara, E; Murphy, TM; O'Connell, A; O'Loughlin, J; Rooney, N | 1 |
| Cid, D; de la Fuente, R; Díez, R; Martínez, S; Orden, JA; Ruiz-Santa-Quiteria, JA | 1 |
| Petersen, U | 1 |
| Jun, MJ; Kim, KM; Kim, YS; Sohn, YS; Song, R | 1 |
| Hayakawa, H; Kawamura, Y; Miyazaki, M; Nagasawa, M; Nakamura, S; Nojima, Y | 1 |
| Jain, A; Rajeswari, MR | 1 |
| Pedersen, K; Wedderkopp, A | 1 |
| Lin, J; Luo, N; Michel, LO; Sahin, O; Zhang, Q | 1 |
| Chatterji, M; Nagaraja, V; Sengupta, S | 1 |
| Avrain, L; Humbert, F; Kempf, I; L'Hospitalier, R; Sanders, P; Vernozy-Rozand, C | 1 |
| Guerra, B; Helmuth, R; Malorny, B; Schroeter, A | 1 |
| Blanco, MM; Domínguez, L; Fernández-Garayzábal, JF; Gibello, A; Liébana, P; Moreno, MA; Porrero, MC; Vela, AI | 1 |
| Delsol, AA; Roe, JM; Woodward, MJ | 1 |
| Chiang, CH; Lu, DW; Tai, MC | 1 |
| Bartelt, E; Beckmann, L; Klein, G; Luber, P; Müller, M; Schrader, C | 1 |
| Capilla, S; Castillo, J; Gómez-Lus, R; Goñi, P; Jiménez de Anta, MT; Rubio, MC; Ruiz, J; Vila, J | 1 |
| Chang, CF; Chang, YF; Huang, TM | 1 |
| Cebula, TA; Levy, DD; Sharma, B | 1 |
| Murakawa, GJ; Sable, D | 1 |
| Cilla, G; Gomáriz, M; Marimón, JM; Pérez-Trallero, E; Zigorraga, C | 1 |
| Mammeri, H; Martinez-Martinez, L; Nordmann, P; Poirel, L; Van De Loo, M | 1 |
| Hänninen, ML; Laatu, M; Rautelin, H | 1 |
| Holzgrabe, U; Kiefer, W; Neugebauer, U; Popp, J; Schmitt, M; Szeghalmi, A | 1 |
| Abba, M; Donnelly, J; Hussain, B; Shervington, LA | 1 |
| Gajewski, A; Horcajada, JP; Jiménez de Anta, MT; Johnson, JR; Mensa, J; Smithson, A; Soto, S; Vila, J | 1 |
| Mammeri, H; Nordmann, P; Poirel, L; Van De Loo, M | 1 |
| Connors, W; Maheshwary, S; Narayanan, S; Printz, M; Richert, C; Riedrich, M; Siegmund, K | 1 |
| Beaudeau, F; Belloc, C; Lam, DN; Laval, A; Pellerin, JL | 1 |
| Hakanen, AJ; Huovinen, P; Jalava, J; Kotilainen, P; Lindgren, M; Siitonen, A | 1 |
| Corcoran, D; Cotter, L; Fanning, S; O'Halloran, F; Quinn, T | 1 |
| Depta, JP; Pichler, WJ; Schmid, DA | 1 |
| Cardinale, E; Mead, G; Perrier Gros-Claude, JD; Rivoal, K; Rose, V; Salvat, G; Tall, F | 1 |
| Romero, IC; Saravia, NG; Walker, J | 1 |
| Bahsoun, I; Boye, CS; Breurec, S; Cardinale, E; Garin, B; Kinana, AD; Perrier-Gros-Claude, JD; Sire, JM; Tall, F | 1 |
| de Jong, A; Friederichs, S; Kehrenberg, C; Michael, GB; Schwarz, S | 1 |
| Chakraborty, R; Datta, B; Ghosh, A; Kaundal, A; Mukhopadhyay, AK; Ramamurthy, T; Srinivasan, VB; Virk, RK | 1 |
| Drlica, K; Malik, M; Zhao, X | 1 |
| Bonnet, R; Bouziges, N; Cavalie, L; Delmas, J; Jean-Pierre, H; Lavigne, JP; Lecaillon, E; Marchandin, H; Sotto, A | 1 |
| Drlica, K; Hussain, S; Malik, M | 1 |
| Bahsoun, I; Breurec, S; Cardinale, E; Garin, B; Kinana, AD; Perrier-Gros-Claude, JD; Saad-Bouh Boye, C; Sire, JM; Tall, F | 1 |
| Lee, KE; Lee, Y | 1 |
| Aarestrup, FM; Cavaco, LM; Frimodt-Møller, N; Guardabassi, L; Hasman, H; Nielsen, L | 1 |
| Alba, V; Alcalde, E; Blasco, MD; Esteve, C; Marti, S; Sánchez-Céspedes, J; Vila, J | 1 |
| Brown, DJ; Coia, JE; Mather, H; Murray, A | 1 |
| Hiramatsu, K; Kikuchi, K; Ohtsuka, M; Ono, Y; Sasaki, T; Shimizu, K; Takahashi, N | 1 |
| Capecci, J; Drlica, K; Malik, M | 1 |
| Hayashi, A; Inoue, K; Kamakura, K; Kashiwagi, E; Kawahara, R; Seto, K; Taguchi, M; Yamagata, N | 1 |
| Abdi, A; Bouchakour, M; Djahoudi, A; Meradi, L; Perrier Gros Claude, JD; Timinouni, M | 1 |
| Alvarado, D; del Valle, LJ; Flores, L; García-de-la-Guarda, R; Ibañez, ZB; Quispe, RL; Ramírez, P; Ruiz, J; Vargas, M | 1 |
| Fàbrega, A; Lunn, AD; Sánchez-Céspedes, J; Vila, J | 1 |
| Arias, A; Castillo, FJ; Gude, MJ; Seral, C | 1 |
| Geng, J; Han, X; Lu, T; Zhang, L | 1 |
| Cerniglia, CE; Deck, J; Foley, S; Nawaz, MS; Nguyen, K; Tran, QT | 1 |
| Goessens, WH; Hassing, RJ; Menezes, GA; Petit, PL; van Genderen, PJ; van Pelt, W | 1 |
| Kim, KY; Kwak, HS; Park, JH; Woo, GJ | 1 |
| Jang, GC; Jung, SC; Kim, A; Kim, MJ; Kim, TS; Lee, HS; Lim, SK; Nam, HM; Tamang, MD | 1 |
| Figueira, V; Manaia, CM; Silva, M; Vaz-Moreira, I | 1 |
| Arlet, G; Emond, JP; Smati, M; Tankovic, J | 1 |
| Akiyama, T; Khan, AA | 1 |
| Chu, MT; Ling, JM; Lo, NW | 1 |
| Cui, S; Cui, X; Gu, Y; Hou, X; Lin, L; Ren, X; Xu, X | 1 |
| Chae, MH; Gurung, M; Jang, GC; Jung, SC; Kim, SR; Lim, SK; Nam, HM; Tamang, MD | 1 |
| Cho, JK; Kim, JH; Kim, KS | 1 |
| Carson, L; Irwin, NJ; McCoy, CP | 1 |
| Del Valle, LJ; Gomes, C; Mosquito, S; Ochoa, TJ; Pons, MJ; Ruiz, J | 1 |
| Becker, R; Huang, Y; Kaspar, H; Mankertz, J; Michael, GB; Runge, M; Schwarz, S; Steinhagen, D | 1 |
| Hoszowski, A; Wasyl, D; Zając, M | 1 |
| Ballesté-Delpierre, C; Fàbrega, A; Fernández-Orth, D; Jiménez de Anta, MT; Soto, SM; Vila, J | 1 |
| Abgottspon, H; Hächler, H; Nüesch-Inderbinen, M; Stephan, R; Zurfluh, K | 1 |
| Allum, AG; Grude, N; Henriksen, IH; Jenkins, A; Kristiansen, BE; Strand, L | 1 |
| Blanco, MM; Cutuli, MT; Díaz de Alba, P; Gibello, A; Machuca, J; Rodríguez-Martínez, JM | 1 |
| Firoozeh, F; Soleimani-Asl, Y; Zibaei, M | 1 |
| Meng, J; Meng, X; Shi, X; Wang, D; Wang, X; Wang, Y; Xi, M; Xia, X; Yang, B; Zhang, Z | 1 |
| Debnath, A; Masram, DT; Mogha, NK | 1 |
| Khan, S; Kweon, O; Nawaz, M; Nawaz, S; Steele, R; Sung, K | 1 |
| Alonso-Sanz, M; González-Abad, MJ | 1 |
| Bisacchi, GS | 1 |
| Botello, E; García-Cañas, A; González-Soltero, R; Mendoza-Chamizo, B; Mohedano, RB | 1 |
| Chai, LC; Ngoi, ST; Teh, CS; Thong, KL | 1 |
| Doménech, E; Fenollar, A; Ferrús, MA; Jiménez-Belenguer, A; Villagrá, A | 1 |
| Albornoz, E; Andres, P; Centrón, D; Corso, A; Galas, M; Guerriero, L; Lucero, C; Petroni, A; Quiroga, MP; Rapoport, M; Rodriguez, C; Romero, G | 1 |
| Barguigua, A; Bouchrif, B; El Otmani, F; Elmdaghri, N; Karraouan, B; Nayme, K; Timinouni, M; Zerouali, K | 1 |
| Bi, RR; Chen, Y; Fan, WT; Gu, B; Li, Y; Ma, P; Qin, TT | 1 |
| De Silva, BCJ; Heo, GJ; Hossain, S; Pathirana, HNKS; Wimalasena, SHMP | 1 |
| Balasundaram, P; Karuppasamy, R; Krishnamurthy, S; Veerappapillai, S | 1 |
| Braetz, S; Fulde, M; Schwerk, P; Tedin, K; Thompson, A | 1 |
| Cha, SY; Choi, SW; Jang, HK; Kang, M; Wei, B | 1 |
| de Oca Jiménez, RM; Macías-Farrera, GP; Monroy-Salazar, HG; Rivera-Ramírez, F; Tenorio-Borroto, E; Varela-Guerrero, J; Yong-Angel, G | 1 |
| Drlica, K; Hong, Y; Luan, G; Zhao, X | 1 |
| Campioni, F; Costa, RG; Falcão, JP; Fernandes, SA; Gomes, CN; Passaglia, J; Rodrigues, DP; Tiba Casas, MR; Vilela, FP | 1 |
| De Silva, BCJ; Heo, GJ; Hossain, S; Pathirana, HNKS; Shin, GW; Wimalasena, SHMP | 1 |
| Hidalgo, AA; Millanao, AR; Mora, AY; Mora, GC; Saavedra, CP; Valenzuela, LM; Villagra, NA | 1 |
| Noguchi, N; Tanaka, E; Wajima, T | 1 |
| Drlica, K; Gao, Q; Hong, Y; Huang, H; Li, Q; Xie, J; Zhao, X | 1 |
| Bao, C; Bao, J; Cheng, S; Dong, C; Gu, B; Hong, J; Jin, D; Liu, G; Qian, H; Tan, Z | 1 |
| Boqvist, S; Emanuelson, U; Fernström, LL; Frosth, S; Hansson, I; Tamminen, LM | 1 |
| Ayodele, O; Khanye, S; Mothibe, M; Sibiya, N | 1 |
| Gunardi, WD; Moehario, LH; Nainggolan, IM; Nathania, I; Nusatia, ACM; Tjoa, E; Yasmon, A | 1 |
| Ahmed, F; Akter, A; Alam, S; Jafar, T; Saha, O; Saha, SR; Sultana, KF | 1 |
| Feglo, PK; Sah, AK | 1 |
| Medina, AM; Ochoa, TJ; Pons, MJ; Rivera, FP; Riveros, M; Ruiz, J | 1 |
5 review(s) available for nalidixic acid and carbostyril
| Article | Year |
|---|---|
[Fluoroquinolones (gyrase inhibitors)].
Topics: Chemical Phenomena; Chemistry; Nalidixic Acid; Quinolines; Quinolones; Topoisomerase II Inhibitors | 1988 |
Sequence-specific DNA damage induced by UVA radiation in the presence of endogenous and exogenous photosensitizers.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Anti-Infective Agents; Carcinogens; Cell Transformation, Neoplastic; Deoxyguanosine; DNA; DNA Adducts; DNA Damage; Fluoroquinolones; Guanine; Humans; Models, Chemical; Mutagenesis; Nalidixic Acid; Neoplasms, Radiation-Induced; Oxidation-Reduction; Oxygen; Pteridines; Pterins; Quinolones; Radiation-Sensitizing Agents; Singlet Oxygen; Skin Neoplasms; Sunlight; Superoxides; Ultraviolet Rays | 2001 |
[The evolution of quinolone: from nalidixic acid to the quinolones of the third generation].
Topics: Anti-Infective Agents; History, 20th Century; Molecular Structure; Nalidixic Acid; Quinolones | 2001 |
Quinolones in dermatology.
Topics: Anti-Infective Agents; Area Under Curve; Bacterial Infections; Biological Availability; Ciprofloxacin; Fluoroquinolones; Humans; Intestinal Absorption; Microbial Sensitivity Tests; Nalidixic Acid; Quinolones; Skin Diseases; Structure-Activity Relationship | 2004 |
Origins of the Quinolone Class of Antibacterials: An Expanded "Discovery Story".
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Discovery; History, 20th Century; History, 21st Century; Humans; Nalidixic Acid; Quinolones | 2015 |
147 other study(ies) available for nalidixic acid and carbostyril
| Article | Year |
|---|---|
Lipid peroxidation and loss of potassium from red blood cells produced by phototoxic quinolones.
Topics: 4-Quinolones; Anti-Infective Agents; Cell Membrane Permeability; Cholesterol; Chromatography, High Pressure Liquid; Erythrocytes; Humans; Lipid Peroxidation; Nalidixic Acid; Oxidation-Reduction; Oxolinic Acid; Photolysis; Potassium; Quinolones | 1992 |
Characterization of high-level quinolone resistance in Campylobacter jejuni.
Topics: Anti-Infective Agents; Campylobacter jejuni; Ciprofloxacin; DNA Topoisomerases, Type II; DNA, Superhelical; Drug Resistance, Microbial; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Norfloxacin; Quinolones; Topoisomerase II Inhibitors | 1991 |
Mechanistic studies of the phototoxic potential of PD 117596, a quinolone antibacterial compound.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Antioxidants; Ciprofloxacin; Dose-Response Relationship, Drug; Fluoroquinolones; Free Radical Scavengers; Hemolysis; Male; Mice; Mice, Inbred Strains; Nalidixic Acid; Nitroso Compounds; Oxygen; Photochemistry; Photolysis; Quinolones; Thiobarbiturates | 1991 |
Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Enterobacter cloacae; Enterobacteriaceae; Escherichia coli; Fluoroquinolones; Klebsiella pneumoniae; Mutation; Nalidixic Acid; Phenotype; Quinolones; Serratia marcescens; Species Specificity | 1991 |
Treatment of multiresistant Salmonella infection.
Topics: Drug Resistance, Microbial; Humans; India; Nalidixic Acid; Quinolones; Salmonella Infections; Salmonella typhimurium | 1991 |
Passive role of articular chondrocytes in quinolone-induced arthropathy in guinea pigs.
Topics: Animals; Cartilage Diseases; Cartilage, Articular; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Guinea Pigs; Iodoacetates; Male; Metalloendopeptidases; Microbial Collagenase; Nalidixic Acid; Peptide Hydrolases; Quinolones | 1990 |
Susceptibility pattern of bacterial isolates to lomefloxacin.
Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Nalidixic Acid; Norfloxacin; Quinolones | 1990 |
Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug--DNA binding model.
Topics: Anti-Bacterial Agents; DNA; DNA, Bacterial; Models, Molecular; Molecular Conformation; Nalidixic Acid; Nucleic Acid Conformation; Protein Conformation; Quinolones; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1989 |
Temafloxacin disk potency and tentative interpretive criteria for susceptibility tests.
Topics: Anti-Infective Agents; Bacteria; Drug Resistance, Microbial; Enterobacteriaceae; Fluoroquinolones; Microbial Sensitivity Tests; Nalidixic Acid; Quinolones; Regression Analysis | 1989 |
Serum protein binding of lomefloxacin, a new antimicrobial agent, and its related quinolones.
Topics: Animals; Anti-Infective Agents; Blood Proteins; Dogs; Fluoroquinolones; Humans; Nalidixic Acid; Ofloxacin; Protein Binding; Quinolones; Rats; Species Specificity | 1989 |
Susceptibility of Campylobacter pylori isolated from pediatric and adult patients to seven new quinolone antibiotics and nalidixic acid.
Topics: Adult; Campylobacter; Child; Child, Preschool; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Quinolones | 1988 |
Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor.
Topics: Animals; Ciprofloxacin; Diclofenac; Drug Synergism; GABA Antagonists; In Vitro Techniques; Male; Muscimol; Nalidixic Acid; Ofloxacin; Quinolones; Rats; Rats, Inbred Strains; Receptors, GABA-A; Theophylline | 1988 |
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
Topics: 4-Quinolones; Aeromonas; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter fetus; Cinoxacin; Ciprofloxacin; Diarrhea; Enoxacin; Fluoroquinolones; Humans; In Vitro Techniques; Intestines; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Salmonella; Shigella; Vibrio cholerae; Vibrio parahaemolyticus; Yersinia enterocolitica | 1985 |
The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
Topics: 4-Quinolones; Anti-Infective Agents; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Streptococcus pneumoniae | 1985 |
Comparative in vitro studies with 4-quinolone antimicrobials.
Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1985 |
[Gyrase inhibitor].
Topics: 4-Quinolones; Anti-Bacterial Agents; Bacteria; Cinoxacin; Drug Resistance, Microbial; Humans; Nalidixic Acid; Ofloxacin; Oxazines; Pipemidic Acid; Quinolines; Quinolones; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1985 |
Monocyclic and tricyclic analogs of quinolones: mechanism of action.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; DNA Replication; DNA Topoisomerases, Type II; DNA, Bacterial; DNA, Superhelical; Escherichia coli; Klebsiella pneumoniae; Nalidixic Acid; Nicotinic Acids; Oxolinic Acid; Quinolines; Quinolones; Staphylococcus aureus; Structure-Activity Relationship | 1987 |
Inhibition of conjugal transfer by new quinolinic compounds.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Conjugation, Genetic; Escherichia coli; Nalidixic Acid; Norfloxacin; Quinolines; Quinolones | 1985 |
In vitro activities of PD 117,596 and reference antibiotics against 448 clinical bacterial strains.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Colony Count, Microbial; Fluoroquinolones; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Nalidixic Acid; Quinolones | 1988 |
Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
Topics: 4-Quinolones; Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Escherichia coli; Fluoroquinolones; Mutation; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pipemidic Acid; Quinolines; Quinolizines; Quinolones | 1986 |
The in-vitro activity of EN 272, a quinolone-7-carboxylic acid, in comparison with other quinolones.
Topics: Anti-Bacterial Agents; Bacteria; Enoxacin; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Quinolines; Quinolones; Structure-Activity Relationship; Urinary Tract Infections | 1985 |
Distribution of quinoline carboxylic acid derivatives in the dog prostate.
Topics: 4-Quinolones; Administration, Oral; Animals; Anti-Infective Agents; Dogs; Drug Evaluation, Preclinical; Infusions, Parenteral; Male; Nalidixic Acid; Norfloxacin; Prostate; Prostatitis; Quinolines; Quinolones; Time Factors; Tissue Distribution; Urinary Tract Infections | 1983 |
[Comparative in vitro effect of 7 quinolones on Ureaplasma urealyticum].
Topics: 4-Quinolones; Anti-Bacterial Agents; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Ureaplasma | 1983 |
The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro.
Topics: 4-Quinolones; Anti-Bacterial Agents; Chlamydia trachomatis; Ciprofloxacin; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Mycoplasma; Nalidixic Acid; Norfloxacin; Oxolinic Acid; Oxytetracycline; Quinolines; Quinolones; Ureaplasma | 1984 |
In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae.
Topics: 4-Quinolones; Anti-Bacterial Agents; Ciprofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Neisseria gonorrhoeae; Norfloxacin; Quinolines; Quinolones; Spectinomycin | 1984 |
Distribution of ciprofloxacin in the dog prostate and various tissues.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Body Fluids; Ciprofloxacin; Dogs; Hydrogen-Ion Concentration; Infusions, Parenteral; Male; Nalidixic Acid; Norfloxacin; Prostate; Quinolines; Quinolones; Tissue Distribution | 1984 |
In vitro antibacterial activity of three new quinolone derivatives: rosoxacin, norfloxacin, pefloxacin.
Topics: 4-Quinolones; Anti-Infective Agents; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Nalidixic Acid; Norfloxacin; Pefloxacin; Quinolines; Quinolones; Species Specificity | 1984 |
[Acrosoxacin (rosoxacin) sensitivity of Neisseria strains].
Topics: 4-Quinolones; Anti-Infective Agents; Microbial Sensitivity Tests; Nalidixic Acid; Neisseria gonorrhoeae; Quinolines; Quinolones | 1984 |
Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae.
Topics: 4-Quinolones; Anti-Bacterial Agents; beta-Lactamases; Microbial Sensitivity Tests; Nalidixic Acid; Neisseria gonorrhoeae; Norfloxacin; Quinolines; Quinolones | 1981 |
A novel gyrB mutation in a fluoroquinolone-resistant clinical isolate of Salmonella typhimurium.
Topics: Anti-Infective Agents; Base Sequence; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type II; DNA, Bacterial; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Nalidixic Acid; Quinolones; Salmonella typhimurium | 1995 |
[Effectiveness of new quinolones in experimental aerogenic plague infection of albino mice].
Topics: 4-Quinolones; Administration, Inhalation; Animals; Anti-Infective Agents; Ciprofloxacin; Drug Evaluation, Preclinical; Lethal Dose 50; Mice; Nalidixic Acid; Pefloxacin; Plague; Quinolones | 1994 |
Quinolone resistance in veterinary isolates of Salmonella.
Topics: Animals; Anti-Infective Agents; Chickens; Ciprofloxacin; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Microbial; Enrofloxacin; Fluoroquinolones; Lipopolysaccharides; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Poultry Diseases; Quinolones; Salmonella; Salmonella Infections, Animal; Turkeys | 1994 |
Correlation between umuC induction and Salmonella mutagenicity assay for quinolone antimicrobial agents.
Topics: Anti-Infective Agents; Bacterial Proteins; Ciprofloxacin; DNA-Directed DNA Polymerase; Enoxacin; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Gene Expression Regulation, Bacterial; Mutagenicity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Quinolones; Salmonella typhimurium; SOS Response, Genetics; Species Specificity | 1993 |
High-performance liquid chromatographic determination of nalidixic acid in rat serum, brain and cerebrospinal fluid.
Topics: Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Male; Nalidixic Acid; Quinolones; Rats; Rats, Wistar; Reproducibility of Results | 1993 |
Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in India.
Topics: Amino Acid Sequence; Base Sequence; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Nalidixic Acid; Ofloxacin; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Quinolones; Salmonella typhi | 1996 |
Fluoroquinolone antibacterials enhance UVA-induced skin tumors.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Female; Fleroxacin; Fluoroquinolones; Mice; Nalidixic Acid; Neoplasms, Radiation-Induced; Ofloxacin; Quinolones; Skin Neoplasms; Ultraviolet Rays | 1997 |
Quinolone antibacterials: a new class of photochemical carcinogens.
Topics: Animals; Anti-Infective Agents; Carcinoma, Squamous Cell; Ciprofloxacin; Dermatitis, Phototoxic; Fleroxacin; Fluoroquinolones; Methoxsalen; Mice; Mice, Hairless; Nalidixic Acid; Neoplasms, Radiation-Induced; Ofloxacin; Papilloma; Quinolones; Skin Neoplasms | 1997 |
Discoordinate gene expression of gyrA and gyrB in response to DNA gyrase inhibition in Escherichia coli.
Topics: Aminocoumarins; beta-Galactosidase; Blotting, Southern; Cloning, Molecular; Coumarins; DNA Gyrase; DNA Topoisomerases, Type II; DNA, Bacterial; DNA, Superhelical; Electrophoresis, Agar Gel; Escherichia coli; Gene Expression Regulation, Bacterial; Genes, Reporter; Lac Operon; Nalidixic Acid; Novobiocin; Oxolinic Acid; Plasmids; Protein Biosynthesis; Quinolones; Topoisomerase II Inhibitors | 1997 |
Biological activity of new aza analogues of quinolones.
Topics: Animals; Anti-Infective Agents; Aza Compounds; Enterobacteriaceae; Euglena gracilis; Microbial Sensitivity Tests; Nalidixic Acid; Plasmids; Plastids; Quinolones | 1997 |
The effects of increasing levels of quinolone resistance on in-vitro activity of four quinolones.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Ofloxacin; Quinolones | 1998 |
Photocleavage of DNA by the fluoroquinolone antibacterials.
Topics: Anti-Infective Agents; DNA Damage; Enoxacin; Fleroxacin; Fluoroquinolones; Nalidixic Acid; Norfloxacin; Photolysis; Plasmids; Quinolones; Structure-Activity Relationship; Ultraviolet Rays | 1998 |
[Growing incidence of nalidixic acid resistance and sensitivity to quinolones in Salmonella typhimurium strains isolated from man or animal].
Topics: Animals; Anti-Infective Agents; Cattle; Chickens; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Quinolones; Salmonella typhimurium; Swine | 1998 |
Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli.
Topics: Anti-Infective Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Ciprofloxacin; Diffusion; Dose-Response Relationship, Drug; Enoxacin; Enrofloxacin; Escherichia coli; Fluorescence; Fluoroquinolones; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Nalidixic Acid; Pseudomonas aeruginosa; Quinolones; Spheroplasts; Staphylococcus aureus; Temperature | 1999 |
Mechanisms of resistance to ampicillin, chloramphenicol and quinolones in multiresistant Salmonella typhimurium strains isolated from fish.
Topics: Ampicillin; Animals; Chloramphenicol; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Drug Resistance, Multiple; Fishes; Gentamicins; Microbial Sensitivity Tests; Nalidixic Acid; Nitrofurantoin; Polymerase Chain Reaction; Quinolones; Salmonella typhimurium; Tetracycline; Tobramycin | 1999 |
Incidence of quinolone resistance over the period 1986 to 1998 in veterinary Salmonella isolates from Germany.
Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; Cattle; Drug Resistance, Microbial; Enrofloxacin; Fluoroquinolones; Germany; Incidence; Microbial Sensitivity Tests; Nalidixic Acid; Poultry; Quinolones; Salmonella enterica; Salmonella Infections, Animal; Salmonella typhimurium; Serotyping; Swine | 1999 |
Novel action of quinolones on osteoclast-like cells.
Topics: Animals; Cells, Cultured; Dinoprostone; Histocytochemistry; Male; Mice; Nalidixic Acid; Norfloxacin; Ofloxacin; Osteoclasts; Quinolones; Spleen; Tumor Necrosis Factor-alpha | 1999 |
Distinct mechanisms of guanine-specific DNA photodamage induced by nalidixic acid and fluoroquinolone antibacterials.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Anti-Infective Agents; Binding Sites; Deoxyguanosine; DNA; DNA Damage; Electron Transport; Fluoroquinolones; Free Radical Scavengers; Genes, p53; Genes, ras; Guanine; Humans; In Vitro Techniques; Nalidixic Acid; Proto-Oncogene Mas; Quinolones; Ultraviolet Rays | 2000 |
Characterization of high-level fluoroquinolone resistance in Escherichia coli O78:K80 isolated from turkeys.
Topics: Amino Acid Substitution; Animals; Anti-Infective Agents; Bacterial Proteins; Blotting, Western; Carrier Proteins; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Bacterial; Drug Resistance, Microbial; Enrofloxacin; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Lipoproteins; Membrane Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Mutation; Nalidixic Acid; Quinolizines; Quinolones; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Turkeys | 2001 |
A 2'-acylamido cap that increases the stability of oligonucleotide duplexes.
Topics: Anti-Infective Agents; Base Pairing; Deoxyuridine; Molecular Structure; Nalidixic Acid; Nucleic Acid Conformation; Nucleic Acid Hybridization; Oligonucleotides; Quinolones; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Temperature; Ultraviolet Rays | 2001 |
Epidemiological studies of human and animal Salmonella typhimurium DT104 and DT104b isolates in Ireland.
Topics: Animals; Anti-Infective Agents; Bacterial Typing Techniques; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Enrofloxacin; Fluoroquinolones; Humans; Ireland; Microbial Sensitivity Tests; Nalidixic Acid; Polymorphism, Restriction Fragment Length; Quinolones; Salmonella Infections; Salmonella Infections, Animal; Salmonella typhimurium | 2001 |
Quinolone resistance in potentially pathogenic and non-pathogenic Escherichia coli strains isolated from healthy ruminants.
Topics: Animals; Anti-Infective Agents; Cattle; Ciprofloxacin; Enrofloxacin; Escherichia coli; Fluoroquinolones; Goats; Microbial Sensitivity Tests; Nalidixic Acid; Quinolones; Ruminants; Sheep | 2001 |
Synthesis, characterization and antitumor activity of quinolone-platinum(II) conjugates.
Topics: Animals; Antineoplastic Agents; Carboplatin; Fluoroquinolones; Leukemia L1210; Magnetic Resonance Spectroscopy; Models, Chemical; Molecular Structure; Nalidixic Acid; Oxolinic Acid; Platinum; Quinolizines; Quinolones; Spectrophotometry, Infrared; Tumor Cells, Cultured | 2001 |
[Phototoxicity studies of pazufloxacin mesilate, a novel parenteral quinolone antimicrobial agent--in vitro and in vivo studies].
Topics: Animals; Anti-Infective Agents; Cells, Cultured; Ciprofloxacin; Dermatitis, Phototoxic; Enoxacin; Female; Fluoroquinolones; Guinea Pigs; Nalidixic Acid; Ofloxacin; Oxazines; Quinolones; Rats; Rats, Sprague-Dawley; Ultraviolet Rays | 2002 |
Preferential binding of quinolones to DNA with alternating G, C / A, T sequences: a spectroscopic study.
Topics: Base Pairing; Base Sequence; Circular Dichroism; DNA, Bacterial; Escherichia coli; Molecular Structure; Nalidixic Acid; Nucleic Acid Conformation; Oxolinic Acid; Polynucleotides; Quinolones; Spectrometry, Fluorescence; Spectrophotometry; Spectrophotometry, Ultraviolet; Structure-Activity Relationship | 2002 |
Resistance to quinolones in Campylobacter jejuni and Campylobacter coli from Danish broilers at farm level.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Typing Techniques; Campylobacter coli; Campylobacter jejuni; Cephalothin; Culture Media; Denmark; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enrofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Nalidixic Acid; Poultry; Quinolones | 2003 |
In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump.
Topics: Animals; Anti-Infective Agents; Campylobacter Infections; Campylobacter jejuni; Chickens; Ciprofloxacin; DNA Gyrase; Drug Resistance, Microbial; Enrofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Quinolones | 2003 |
Chromosomally encoded gyrase inhibitor GyrI protects Escherichia coli against DNA-damaging agents.
Topics: Alkylating Agents; beta-Galactosidase; Ciprofloxacin; DNA Damage; DNA, Bacterial; DNA, Superhelical; Enzyme Inhibitors; Escherichia coli; Escherichia coli Proteins; Genes, Bacterial; Genes, Reporter; Methylnitronitrosoguanidine; Mitomycin; Mutagenesis; Nalidixic Acid; Plasmids; Quinolones; Repressor Proteins; SOS Response, Genetics; Topoisomerase II Inhibitors; Ultraviolet Rays | 2003 |
Antimicrobial resistance in Campylobacter from broilers: association with production type and antimicrobial use.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Chickens; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enrofloxacin; Erythromycin; Fluoroquinolones; Gentamicins; Microbial Sensitivity Tests; Nalidixic Acid; Polymerase Chain Reaction; Poultry Diseases; Quinolones; Tetracycline | 2003 |
Incidence of quinolone resistance in strains of Salmonella isolated from poultry, cattle and pigs in Germany between 1998 and 2001.
Topics: Amino Acid Sequence; Animals; Anti-Infective Agents; Cattle; Ciprofloxacin; Colony Count, Microbial; DNA, Bacterial; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fluoroquinolones; Incidence; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Poultry; Quinolones; Salmonella; Salmonella Infections, Animal; Serotyping; Swine | 2003 |
Analysis of the gyrA gene of clinical Yersinia ruckeri isolates with reduced susceptibility to quinolones.
Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Anti-Infective Agents; DNA Gyrase; Drug Resistance, Bacterial; Fish Diseases; Microbial Sensitivity Tests; Molecular Sequence Data; Nalidixic Acid; Oncorhynchus mykiss; Oxolinic Acid; Quinolones; Yersinia ruckeri | 2004 |
Effect of a 5 day enrofloxacin treatment on Salmonella enterica serotype Typhimurium DT104 in the pig.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Cyclohexanes; DNA Gyrase; Drug Resistance, Bacterial; Enrofloxacin; Feces; Fluoroquinolones; Genes, Bacterial; Microbial Sensitivity Tests; Nalidixic Acid; Phenotype; Quinolones; Salmonella enterica; Salmonella Infections; Swine | 2004 |
Corneal and scleral permeability of quinolones--a pharmacokinetics study.
Topics: Administration, Topical; Animals; Aqueous Humor; Cell Membrane Permeability; Cinoxacin; Ciprofloxacin; Conjunctiva; Cornea; Enoxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones; Rabbits; Sclera; Time Factors; Water | 2003 |
Analysis of gyrA mutations in quinolone-resistant and -susceptible Campylobacter jejuni isolates from retail poultry and human clinical isolates by non-radioactive single-strand conformation polymorphism analysis and DNA sequencing.
Topics: Animals; Base Sequence; Campylobacter Infections; Campylobacter jejuni; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Food Microbiology; Genes, Bacterial; Humans; Mutation; Mutation, Missense; Nalidixic Acid; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Poultry; Quinolones | 2004 |
Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates.
Topics: Anti-Infective Agents; Ciprofloxacin; Dipeptides; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Quinolones; Spain; Yersinia enterocolitica; Yersinia Infections | 2004 |
Detection of mutations in the gyrA gene and class I integron from quinolone-resistant Salmonella enterica serovar Choleraesuis isolates in Taiwan.
Topics: Animals; Anti-Infective Agents; Base Sequence; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Integrons; Molecular Sequence Data; Nalidixic Acid; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Quinolones; Salmonella enterica; Salmonella Infections, Animal; Sequence Alignment; Swine; Swine Diseases; Taiwan | 2004 |
Single-nucleotide polymorphism mutation spectra and resistance to quinolones in Salmonella enterica serovar Enteritidis with a mutator phenotype.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Base Pair Mismatch; Chloramphenicol; Ciprofloxacin; DNA Gyrase; DNA Primers; DNA Probes; DNA Repair; DNA Topoisomerase IV; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Phenotype; Polymorphism, Single Nucleotide; Quinolones; Salmonella enterica; Salmonella Infections | 2004 |
Increasing prevalence of quinolone resistance in human nontyphoid Salmonella enterica isolates obtained in Spain from 1981 to 2003.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Feces; Food Microbiology; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Salmonella enterica; Salmonella Infections; Salmonella typhimurium; Spain | 2004 |
Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe.
Topics: Anti-Infective Agents; Base Sequence; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Europe; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Nalidixic Acid; Plasmids; Polymerase Chain Reaction; Quinolones; Sequence Analysis, DNA | 2005 |
Susceptibility of Campylobacter hyointestinalis subsp. hyointestinalis to antimicrobial agents and characterization of quinolone-resistant strains.
Topics: Animals; Campylobacter hyointestinalis; Cattle; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Quinolones; Reindeer | 2005 |
Vibrational spectroscopic characterization of fluoroquinolones.
Topics: Aza Compounds; Cinoxacin; Ciprofloxacin; DNA Gyrase; DNA, Bacterial; Enoxacin; Enzyme Inhibitors; Fluoroquinolones; Hydrogen Bonding; Hydrogen-Ion Concentration; Models, Chemical; Models, Molecular; Models, Theoretical; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxolinic Acid; Quinolines; Quinolones; Spectrophotometry, Infrared; Spectrum Analysis, Raman; Temperature; Ultraviolet Rays; Vibration; Water | 2005 |
The simultaneous separation and determination of five quinolone antibiotics using isocratic reversed-phase HPLC: application to stability studies on an ofloxacin tablet formulation.
Topics: Anti-Bacterial Agents; Calibration; Chemistry, Pharmaceutical; Chromatography; Chromatography, High Pressure Liquid; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Industry; Drug Stability; Fluoroquinolones; Hydrogen-Ion Concentration; Models, Chemical; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones; Reproducibility of Results; Tablets; Time Factors | 2005 |
Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts.
Topics: Anti-Infective Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Male; Microbial Sensitivity Tests; Nalidixic Acid; Phylogeny; Quinolones; Urologic Diseases; Virulence; Virulence Factors | 2005 |
Association of plasmid-mediated quinolone resistance with extended-spectrum beta-lactamase VEB-1.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacter cloacae; Escherichia coli Proteins; Humans; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Nalidixic Acid; Plasmids; Quinolones; Sequence Analysis, DNA | 2005 |
Molecular details of quinolone-DNA interactions: solution structure of an unusually stable DNA duplex with covalently linked nalidixic acid residues and non-covalent complexes derived from it.
Topics: Base Sequence; DNA; Models, Molecular; Nalidixic Acid; Nuclear Magnetic Resonance, Biomolecular; Nucleic Acid Conformation; Quinolones; Solutions | 2005 |
Effect of quinolone treatment on selection and persistence of quinolone-resistant Escherichia coli in swine faecal flora.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Colony Count, Microbial; Culture Media; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Feces; Fluoroquinolones; Nalidixic Acid; Quinolones; Swine | 2005 |
New quinolone resistance phenomenon in Salmonella enterica: nalidixic acid-susceptible isolates with reduced fluoroquinolone susceptibility.
Topics: Anti-Infective Agents; Asia; Ciprofloxacin; Drug Resistance, Bacterial; Feces; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Nalidixic Acid; Quinolones; Salmonella enterica; Salmonella Infections; Travel | 2005 |
Characterization of a cmeABC operon in a quinolone-resistant Campylobacter coli isolate of Irish origin.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter jejuni; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ireland; Multidrug Resistance-Associated Proteins; Nalidixic Acid; Operon; Quinolones | 2005 |
T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antigen-Presenting Cells; Aza Compounds; Cell Proliferation; Cells, Cultured; Ciprofloxacin; Clone Cells; Cross Reactions; Drug Hypersensitivity; Enoxacin; Female; Fluoroquinolones; Humans; Hypersensitivity, Delayed; Middle Aged; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Patch Tests; Pipemidic Acid; Quinolines; Quinolones; T-Lymphocytes | 2006 |
Genetic characterization and antibiotic resistance of Campylobacter spp. isolated from poultry and humans in Senegal.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter coli; Campylobacter jejuni; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Food Microbiology; Genes, Bacterial; Genetic Variation; Genotype; Humans; Nalidixic Acid; Poultry; Quinolones | 2006 |
Selective action of fluoroquinolones against intracellular amastigotes of Leishmania (Viannia) panamensis in vitro.
Topics: Animals; Cell Line; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Leishmania guyanensis; Macrophages; Nalidixic Acid; Norfloxacin; Ofloxacin; Quinolones | 2005 |
Genetic diversity and quinolone resistance in Campylobacter jejuni isolates from poultry in Senegal.
Topics: Animals; Anti-Infective Agents; Campylobacter jejuni; Chickens; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Genetic Variation; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Poultry; Quinolones; Senegal | 2006 |
Identification of the plasmid-borne quinolone resistance gene qnrS in Salmonella enterica serovar Infantis.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Genes, Bacterial; Nalidixic Acid; Plasmids; Quinolones; Salmonella enterica | 2006 |
Mechanism of drug resistance in clonally related clinical isolates of Vibrio fluvialis isolated in Kolkata, India.
Topics: Anti-Bacterial Agents; DNA Gyrase; Drug Resistance, Bacterial; Hospitalization; Humans; India; Integrases; Integrons; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Plasmids; Quinolones; Vibrio; Vibrio Infections | 2006 |
Lethal fragmentation of bacterial chromosomes mediated by DNA gyrase and quinolones.
Topics: Amino Acid Substitution; Chromosomes, Bacterial; Dimerization; DNA Fragmentation; DNA Gyrase; DNA, Bacterial; Escherichia coli; Fluoroquinolones; Gatifloxacin; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Quinolones | 2006 |
qnrA in CTX-M-producing Escherichia coli isolates from France.
Topics: Anti-Infective Agents; beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; France; Genes, Bacterial; Integrons; Microbial Sensitivity Tests; Nalidixic Acid; Plasmids; Polymerase Chain Reaction; Quinolones | 2006 |
Effect of anaerobic growth on quinolone lethality with Escherichia coli.
Topics: Aerobiosis; Anaerobiosis; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; DNA Fragmentation; DNA Gyrase; DNA, Bacterial; DnaB Helicases; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Models, Biological; Molecular Structure; Nalidixic Acid; Quinolones | 2007 |
Campylobacter coli isolates derived from chickens in Senegal: Diversity, genetic exchange with Campylobacter jejuni and quinolone resistance.
Topics: Alleles; Animals; Anti-Infective Agents; Campylobacter coli; Campylobacter jejuni; Chickens; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Genetic Variation; Nalidixic Acid; Polymerase Chain Reaction; Quinolones; Senegal | 2007 |
Isolation of multidrug-resistant Salmonella typhimurium DT104 from swine in Korea.
Topics: Animals; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Integrons; Intestines; Korea; Nalidixic Acid; Quinolones; Salmonella Infections; Salmonella typhimurium; Swine; Swine Diseases | 2007 |
Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Denmark; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Prevalence; Quinolones; Swine; Swine Diseases | 2008 |
Plasmid-mediated QnrS2 determinant from a clinical Aeromonas veronii isolate.
Topics: Aeromonas; Ciprofloxacin; Drug Resistance, Bacterial; Genes, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Plasmids; Quinolones | 2008 |
Plasmid-mediated quinolone resistance in nalidixic-acid-susceptible strains of Salmonella enterica isolated in Scotland.
Topics: Anti-Bacterial Agents; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Nalidixic Acid; Plasmids; Quinolones; Salmonella enterica; Salmonella Infections; Scotland | 2008 |
Emergence of quinolone-resistant Bordetella pertussis in Japan.
Topics: Anti-Bacterial Agents; Bordetella pertussis; Child; DNA Gyrase; Fluoroquinolones; Humans; Japan; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Quinolones | 2009 |
Lon protease is essential for paradoxical survival of Escherichia coli exposed to high concentrations of quinolone.
Topics: Anti-Infective Agents; Chloramphenicol; Escherichia coli; Escherichia coli Proteins; Mutation; Nalidixic Acid; Protease La; Quinolones | 2009 |
Plasmid-mediated quinolone resistance in Salmonella isolated from patients with overseas travelers' diarrhea in Japan.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Diarrhea; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Japan; Microbial Sensitivity Tests; Nalidixic Acid; Plasmids; Quinolones; Salmonella; Salmonella Infections; Travel | 2009 |
[Qnr and aac (6')-Ib-cr types quinolone resistance among Enterobacteriaceae isolated in Annaba, Algeria].
Topics: Acetyltransferases; Algeria; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Polymerase Chain Reaction; Quinolones | 2011 |
Bartonella bacilliformis, endemic pathogen of the Andean region, is intrinsically resistant to quinolones.
Topics: Anti-Bacterial Agents; Bartonella bacilliformis; Bartonella Infections; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Nalidixic Acid; Quinolones; Sequence Analysis, Protein; Spain | 2010 |
Prevalence of mechanisms decreasing quinolone-susceptibility among Salmonella spp. clinical isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Gastroenteritis; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Polymerase Chain Reaction; Quinolones; Salmonella; Salmonella Infections; Sequence Analysis, DNA; Spain | 2010 |
Molecular mechanisms of quinolone resistance in clinical isolates of Aeromonas caviae and Aeromonas veronii bv. sobria.
Topics: Aeromonas; Amino Acid Substitution; Anti-Bacterial Agents; Dipeptides; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Feces; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Mutation, Missense; Nalidixic Acid; Plasmids; Quinolones | 2010 |
The role of Escherichia coli YrbB in the lethal action of quinolones.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Hydrogen Peroxide; Hydroxyl Radical; Microbial Sensitivity Tests; Mitomycin; Mutation; Nalidixic Acid; Quinolones; Signal Transduction; Ultraviolet Rays | 2011 |
Detection of type III secretion system virulence and mutations in gyrA and parC genes among quinolone-resistant strains of Pseudomonas aeruginosa isolated from imported shrimp.
Topics: Amino Acid Substitution; Animals; Anti-Infective Agents; Bacterial Secretion Systems; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Penaeidae; Polymerase Chain Reaction; Pseudomonas aeruginosa; Quinolones; United States; Virulence | 2011 |
Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Asia, Southeastern; Blood; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Paratyphoid Fever; Plasmids; Polymerase Chain Reaction; Quinolones; Salmonella paratyphi A; Salmonella typhi; Travel; Typhoid Fever | 2011 |
Characterization of the quinolone resistance mechanism in foodborne Salmonella isolates with high nalidixic acid resistance.
Topics: Anti-Infective Agents; Arginine; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Food Microbiology; Meat; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Plasmids; Quinolones; Republic of Korea; Salmonella enterica | 2011 |
Prevalence and mechanisms of quinolone resistance among selected nontyphoid Salmonella isolated from food animals and humans in Korea.
Topics: Animals; Anti-Infective Agents; Bacterial Proteins; Cattle; Chickens; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Food Microbiology; Humans; Korea; Meat; Microbial Sensitivity Tests; Nalidixic Acid; Point Mutation; Poultry; Prevalence; Quinolones; Salmonella; Salmonella Infections; Sequence Analysis, DNA; Swine | 2011 |
Diversity and antibiotic resistance of Aeromonas spp. in drinking and waste water treatment plants.
Topics: Aeromonas; Drinking Water; Drug Resistance, Microbial; Genes, Bacterial; Genetic Variation; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Nalidixic Acid; Phenotype; Phylogeny; Quinolones; RNA, Ribosomal, 16S; Species Specificity; Waste Disposal, Fluid; Water Microbiology; Water Purification | 2011 |
In vivo sequential selection of Escherichia coli with topoisomerase- and efflux-mediated misleading quinolone resistance phenotypes.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type I; Drug Resistance, Bacterial; Escherichia coli; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Ofloxacin; Phenotype; Quinolones; Selection, Genetic; Sequence Analysis, DNA | 2012 |
Isolation and characterization of small qnrS1-carrying plasmids from imported seafood isolates of Salmonella enterica that are highly similar to plasmids of clinical isolates.
Topics: Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Nalidixic Acid; Plasmids; Public Health; Quinolones; Salmonella enterica; Salmonella Infections; Salmonella typhimurium; Seafood; Taiwan; Thailand; United Kingdom; Vietnam | 2012 |
Increasing quinolone resistance and multidrug resistant isolates among Salmonella enterica in Hong Kong.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Feces; Female; Hong Kong; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Phylogeny; Quinolones; Salmonella enterica; Salmonella Infections | 2012 |
Functional characterization of quinolone-resistant mechanisms in a lab-selected Salmonella enterica typhimurium mutant.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests; Nalidixic Acid; Point Mutation; Quinolones; Salmonella enterica; Salmonella typhimurium | 2013 |
Prevalence of plasmid-mediated quinolone resistance determinants among Escherichia coli isolated from food animals in Korea.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Ciprofloxacin; Cluster Analysis; DNA Gyrase; DNA Mutational Analysis; DNA Primers; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Phenotype; Phylogeny; Prevalence; Quinolones; R Factors; Republic of Korea; Swine; Swine Diseases | 2012 |
Prevalence and characterization of plasmid-mediated quinolone resistance genes in Salmonella isolated from poultry in Korea.
Topics: Animals; Blotting, Southern; Ciprofloxacin; DNA Primers; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Gene Transfer, Horizontal; Levofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Plasmids; Polymerase Chain Reaction; Poultry; Poultry Diseases; Quinolones; Republic of Korea; Salmonella; Salmonella Infections, Animal | 2013 |
Effect of pH on the in vitro susceptibility of planktonic and biofilm-grown Proteus mirabilis to the quinolone antimicrobials.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Plankton; Proteus mirabilis; Quinolones | 2013 |
Analysis of quinolone-resistance in commensal and diarrheagenic Escherichia coli isolates from infants in Lima, Peru.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Dipeptides; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Feces; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Nalidixic Acid; Peru; Prevalence; Quinolones | 2014 |
Pheno- and genotypic analysis of antimicrobial resistance properties of Yersinia ruckeri from fish.
Topics: Animals; Anti-Infective Agents; Aquaculture; DNA Gyrase; Drug Resistance, Bacterial; Enrofloxacin; Fish Diseases; Fluoroquinolones; Germany, West; Microbial Sensitivity Tests; Nalidixic Acid; Oncorhynchus mykiss; Phenotype; Quinolones; Yersinia Infections; Yersinia ruckeri | 2014 |
Prevalence and characterisation of quinolone resistance mechanisms in Salmonella spp.
Topics: Amino Acid Substitution; Animal Feed; Animals; Bacterial Proteins; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Microbial Sensitivity Tests; Nalidixic Acid; Phylogeny; Poland; Prevalence; Quinolones; Salmonella; Salmonella Infections, Animal; Species Specificity | 2014 |
Impact of quinolone-resistance acquisition on biofilm production and fitness in Salmonella enterica.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Ciprofloxacin; Drug Resistance, Bacterial; Gene Expression Profiling; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Quinolones; Real-Time Polymerase Chain Reaction; Salmonella Infections; Salmonella typhimurium; Selection, Genetic; Serial Passage | 2014 |
Quinolone resistance mechanisms in Salmonella enterica serovars Hadar, Kentucky, Virchow, Schwarzengrund, and 4,5,12:i:-, isolated from humans in Switzerland, and identification of a novel qnrD variant, qnrD2, in S. Hadar.
Topics: Anti-Bacterial Agents; Base Sequence; DNA Gyrase; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Plasmids; Quinolones; Salmonella enterica; Sequence Analysis, DNA; Serogroup; Switzerland | 2014 |
High levels of multiresistance in quinolone resistant urinary tract isolates of Escherichia coli from Norway; a non clonal phenomen?
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norway; Phylogeny; Quinolones; Species Specificity; Urinary Tract | 2014 |
Lactococcus garvieae carries a chromosomally encoded pentapeptide repeat protein that confers reduced susceptibility to quinolones in Escherichia coli producing a cytotoxic effect.
Topics: Anti-Bacterial Agents; Cell Membrane; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Gene Expression; Lactococcus; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Nalidixic Acid; Quinolones; Recombinant Proteins | 2014 |
Detection of plasmid-mediated qnr genes among the quinolone-resistant Escherichia coli isolates in Iran.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Iran; Microbial Sensitivity Tests; Nalidixic Acid; Plasmids; Quinolones; Urinary Tract Infections | 2014 |
Presence of qnr, aac(6')-Ib, qepA, oqxAB, and mutations in gyrase and topoisomerase in nalidixic acid-resistant Salmonella isolates recovered from retail chicken carcasses.
Topics: Amino Acid Substitution; Animals; Anti-Bacterial Agents; Bacterial Proteins; Chickens; DNA Gyrase; DNA Topoisomerases; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Poultry; Quinolones; Salmonella; Salmonella Food Poisoning | 2014 |
Metal complex of the first-generation quinolone antimicrobial drug nalidixic acid: structure and its biological evaluation.
Topics: Antifungal Agents; Fungi; Metals; Microbial Sensitivity Tests; Nalidixic Acid; Quinolones; Structure-Activity Relationship | 2015 |
Characterisation of novel mutations involved in quinolone resistance in Escherichia coli isolated from imported shrimp.
Topics: Anti-Bacterial Agents; Biological Transport, Active; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Microbial Sensitivity Tests; Models, Molecular; Mutation, Missense; Nalidixic Acid; Point Mutation; Polymerase Chain Reaction; Protein Conformation; Quinolones; Seafood; Selection, Genetic; Sequence Analysis, DNA | 2015 |
[Salmonella enterica with nonclassical quinolone resistance phenotype in pediatric patients].
Topics: Anti-Bacterial Agents; Child; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Phenotype; Quinolones; Salmonella enterica; Salmonella Infections | 2015 |
[Role of double strand DNA break repair for quinolone sensitivity in Escherichia coli: therapeutic implications].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA Breaks, Double-Stranded; DNA Helicases; DNA Repair; DNA Replication; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Exodeoxyribonuclease V; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Targeted Therapy; Nalidixic Acid; Norfloxacin; Quinolones; Rec A Recombinases; Recombinational DNA Repair; Serine Endopeptidases; SOS Response, Genetics | 2015 |
Quinolone Resistance Mechanisms Among Salmonella enterica in Malaysia.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Conjugation, Genetic; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Humans; Malaysia; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Plasmids; Prevalence; Quinolones; Salmonella enterica; Salmonella Infections | 2016 |
Antimicrobial resistance of Escherichia coli isolated in newly-hatched chickens and effect of amoxicillin treatment during their growth.
Topics: Amoxicillin; Animals; Animals, Newborn; Anti-Infective Agents; Chickens; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Infectious Disease Transmission, Vertical; Male; Microbial Sensitivity Tests; Nalidixic Acid; Poultry Diseases; Quinolones | 2016 |
Prevalence of Plasmid-Mediated Quinolone Resistance Genes in Clinical Enterobacteria from Argentina.
Topics: Anti-Bacterial Agents; Argentina; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Plasmids; Prevalence; Quinolones | 2017 |
Genotypic characterization of quinolone resistant-Escherichia coli isolates from retail food in Morocco.
Topics: Anti-Bacterial Agents; DNA Gyrase; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Food Microbiology; Humans; Morocco; Mutation; Nalidixic Acid; Phylogeny; Plasmids; Quinolones; Virulence | 2017 |
Novel mutations in gyrA and parC among Shigella sonnei strains from Jiangsu Province of China, 2002-2011.
Topics: Anti-Bacterial Agents; China; Disk Diffusion Antimicrobial Tests; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Mutation; Nalidixic Acid; Plasmids; Quinolones; Sequence Analysis, DNA; Serotyping; Shigella sonnei | 2017 |
Prevalence and characterisation of quinolone resistance genes in Aeromonas spp. isolated from pet turtles in South Korea.
Topics: Aeromonas; Amino Acid Substitution; Animals; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Genes, Bacterial; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Ofloxacin; Plasmids; Polymerase Chain Reaction; Quinolones; Republic of Korea; Turtles | 2017 |
Drug repurposing: An approach to tackle drug resistance in S. typhimurium.
Topics: Bacterial Proteins; Ciprofloxacin; Databases, Factual; DNA Gyrase; Drug Evaluation, Preclinical; Drug Repositioning; Drug Resistance, Bacterial; Flufenamic Acid; Molecular Dynamics Simulation; Nalidixic Acid; Quinolones; Salmonella typhimurium; Topoisomerase II Inhibitors | 2018 |
The role of ATP pools in persister cell formation in (fluoro)quinolone-susceptible and -resistant strains of Salmonella enterica ser. Typhimurium.
Topics: Adenosine Triphosphate; Animals; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Fluoroquinolones; Mutation; Nalidixic Acid; Quinolones; Salmonella Infections, Animal; Salmonella typhimurium | 2017 |
Molecular Characterization of Fluoroquinolone Resistance Mechanisms of Campylobacter Isolates from Duck Meats.
Topics: Animals; Campylobacter; Campylobacter jejuni; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Ducks; Fluoroquinolones; Meat; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Quinolines; Quinolones | 2017 |
Antibiotics susceptibility of quinolones against Salmonella spp. strains isolated and molecularly sequenced for gyrA gene.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Base Sequence; Disk Diffusion Antimicrobial Tests; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Genes, Bacterial; Mutation; Nalidixic Acid; Quinolones; Salmonella; Salmonella enterica; Salmonella Infections; Swine | 2018 |
Suppression of Reactive Oxygen Species Accumulation Accounts for Paradoxical Bacterial Survival at High Quinolone Concentration.
Topics: Catalase; Escherichia coli; Nalidixic Acid; Quinolones; Reactive Oxygen Species | 2018 |
Genotypic Resistance to Quinolone and Tetracycline in Salmonella Dublin Strains Isolated from Humans and Animals in Brazil.
Topics: Animals; Anti-Bacterial Agents; Brazil; Cattle; Ciprofloxacin; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Plasmids; Polymerase Chain Reaction; Quinolones; Salmonella enterica; Tetracycline | 2019 |
Characterization of Quinolone-Resistant Determinants in Tribe
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Humans; Mutation; Nalidixic Acid; Prevalence; Quinolones; Turtles | 2019 |
Cysteine auxotrophy drives reduced susceptibility to quinolones and paraquat by inducing the expression of efflux-pump systems and detoxifying enzymes in S. Typhimurium.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Cysteine; Drug Resistance, Multiple, Bacterial; Gene Deletion; Gene Expression; Genes, Bacterial; Humans; Levofloxacin; Membrane Transport Proteins; Mutation; Nalidixic Acid; Paraquat; Quinolones; Reactive Oxygen Species; Salmonella typhimurium; Sulfur | 2019 |
Earlier generation quinolones can be useful in identifying Haemophilus influenzae strains with low susceptibility to quinolone isolated from paediatric patients.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Child; Disk Diffusion Antimicrobial Tests; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Japan; Nalidixic Acid; Pipemidic Acid; Quinolones; Sensitivity and Specificity | 2019 |
Reactive oxygen species play a dominant role in all pathways of rapid quinolone-mediated killing.
Topics: Anti-Bacterial Agents; Escherichia coli; Nalidixic Acid; Quinolones; Reactive Oxygen Species | 2020 |
Discovery of seven novel mutations of gyrB, parC and parE in Salmonella Typhi and Paratyphi strains from Jiangsu Province of China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; China; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Quinolones; Salmonella paratyphi A; Salmonella typhi | 2020 |
Occurrence of Campylobacter spp. in Swedish calves, common sequence types and antibiotic resistance patterns.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Cattle; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Feces; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Poultry; Quinolones; Sweden; Whole Genome Sequencing | 2021 |
Fluoroquinolone-induced Glycaemic Aberrations: Could Quinolones be Repurposed to Serve as New Antidiabetic Agents?
Topics: Blood Glucose; Fluoroquinolones; Humans; Hypoglycemia; Hypoglycemic Agents; Nalidixic Acid; Quinolones | 2023 |
Hotspots sequences of gyrA, gyrB, parC, and parE genes encoded for fluoroquinolones resistance from local Salmonella Typhi strains in Jakarta.
Topics: Amino Acids; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Quinolones; Salmonella; Salmonella enterica; Salmonella typhi; Typhoid Fever | 2022 |
Bacterial profile, antimicrobial resistance, and molecular detection of ESBL and quinolone resistance gene of uropathogens causing urinary tract infection in the southeastern part of Bangladesh.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bangladesh; beta-Lactamases; Cefazolin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Quinolones; RNA, Ribosomal, 16S; Urinary Tract Infections | 2023 |
Plasmid-mediated quinolone resistance determinants in clinical bacterial pathogens isolated from the Western Region of Ghana: a cross-sectional study.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Ghana; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Plasmids; Quinolones | 2022 |
Transferable mechanisms of quinolone resistance are more frequent among enterotoxigenic Escherichia coli isolates displaying low-level quinolone resistance.
Topics: Case-Control Studies; Child; Ciprofloxacin; Enterotoxigenic Escherichia coli; Humans; Nalidixic Acid; Quinolones | 2023 |